Greater Occipital Nerve Block for Migraine Prophylaxis
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials
| City: |
|
Phoenix |
| State: |
|
Arizona |
| Zip Code: |
|
85054 |
| Conditions: |
|
Migraine Headache |
| Purpose: |
|
The purpose of this study is to determine whether greater occipital nerve block injection
reduces the frequency of migraine headaches.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Age 18-75 years.
- ICHD-II episodic or chronic migraine.
- At least 1 attack per week.
Exclusion Criteria:
- Pregnant or lactating.
- Continuous headache.
- Maintenance opioid medication.
- Started migraine prophylactic medication within the past 2 months.
- Hypersensitivity to study ingredients.
- Investigational medication within 90 days of screening.
- Injection site infection at injection visit.
- Systemic infection at injection visit.
- Cranial bone defect.
- Chronic cluster headache, new daily persistent headache, hemicrania continua, or
chronic tension type headache.
|
| NCT ID: |
|
NCT00915473 |
| Primary Contact: |
|
Principal Investigator
David W. Dodick, M.D.
Mayo Clinic
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Phoenix, Arizona 85054
United States
There is no listed contact information for this specific location.
Site Status: N/A |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
June 19, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|